Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2012
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/20/2012US8314104 Method of treating diabetes
11/20/2012CA2539975C 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof
11/20/2012CA2496790C Plant extracts stimulating nitric oxide production and their use in the treatment of inflammation and related diseases
11/15/2012US20120288512 Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
11/14/2012EP2522216A1 Production of very long chain polyunsaturated fatty acids in oilseed plants
11/14/2012CN102772413A Low dose entecavir formulation and use
11/14/2012CN101164623B Methods for concentrating virus preparations
11/13/2012US8309767 2-aminobenzoyl derivatives
11/13/2012US8309591 Transmucosal veterinary composition comprising detomidine
11/13/2012CA2526907C Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites
11/08/2012US20120283319 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
11/08/2012US20120283285 Treatment of solid tumors with rapamycin derivatives
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120282673 Functional mutation in respiratory syncytial virus
11/08/2012US20120282323 Dry Liposomal PVP-iodine Compositions
11/08/2012US20120282300 Protein biomaterials and biocoacervates and methods of making and using thereof
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/07/2012CN1505525B Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
11/07/2012CN102764436A Treatment of TNF alpha related disorders
11/07/2012CN102764232A Medical solution, method for producing and use thereof
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012CA2563609C Pharmaceutical compositions for acute glucocorticoid therapy
11/06/2012CA2534358C Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease
11/06/2012CA2497973C Antibiotic microspheres for treatment of infections and osteomyelitis
11/06/2012CA2497921C Vaginal health products
11/01/2012US20120277258 Chemical Compounds
11/01/2012US20120276142 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
11/01/2012US20120276072 Constructs for expressing lysosomal polypeptides
10/2012
10/31/2012EP2517730A2 Vitamin receptor binding drug delivery conjugates
10/31/2012EP2517729A2 Vitamin receptor binding drug delivery conjugates
10/31/2012EP2517722A2 Treatment of T-cell mediated diseases
10/31/2012EP2517721A2 Treatment of T-cell mediated diseases
10/31/2012EP2517719A1 Treatment of T-cell mediated diseases
10/31/2012EP2517718A2 Treatment of T-cell mediated diseases
10/31/2012CN102755646A Medicament for treating TNF alpha related disorder
10/30/2012US8299126 Treatment of canine hemangiosarcoma with a histone deacetylase inhibitor
10/30/2012US8299088 Compositions and methods for treating cancer
10/30/2012US8298799 Hydrolases, nucleic acids encoding them and methods for making and using them
10/30/2012CA2534664C Modafinil compositions
10/25/2012US20120270895 Intranasal Opioid Compositions
10/25/2012US20120269848 Compositions and methods for treating and preventing infection
10/25/2012US20120269763 Compositions and methods for reducing the risk of preterm labor
10/24/2012EP2514743A1 Immunosuppressant Compounds and Compositions
10/24/2012EP2512573A1 Automated treatment system for sleep
10/23/2012US8293484 Method and device for protein delivery into cells
10/23/2012CA2549141C Novel differential imaging method
10/23/2012CA2513567C Cop 1 for treatment of inflammatory bowel diseases
10/23/2012CA2469599C Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/18/2012US20120264821 Use of equol for treating androgen mediated diseases
10/18/2012US20120263744 Compositions And Methods Involving Respiratory Syncytial Virus Subgroup B Strain 9320
10/18/2012US20120263676 Compositions, methods and kits relating to her-2 cleavage
10/18/2012US20120263647 Pro104 Antibody Compositions and Methods of Use
10/17/2012EP2511267A1 3-((n-acylated aminoacyl)amino)pyrazoles as inhibitors of beta-amyloid peptide production useful for the treatment of alzheimer's disease
10/17/2012CN102740919A Automated treatment system for sleep
10/17/2012CN102727861A Treatment of t-cell mediated diseases
10/16/2012US8288442 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
10/16/2012US8288113 Method and device for protein delivery into cells
10/16/2012US8287877 Composition comprising immunogenic microparticles
10/16/2012US8287857 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
10/16/2012US8287504 Ocular drug delivery device
10/16/2012CA2685310C Crystalline and pure modafinil, and process of preparing the same
10/11/2012US20120259022 Pharmaceutical compositions providing enhanced drug concentrations
10/10/2012EP2508608A1 Method of treating neurodegenerative disease
10/10/2012CN1829482B Medicine box for treatment of dependence withdrawal
10/10/2012CN101052414B Immunogenic HBc chimer particles having enhanced stability
10/09/2012CA2546495C Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
10/09/2012CA2535926C N,n-dihalogenated amino acids and derivatives
10/09/2012CA2522191C Delivery vehicle for silver ions
10/09/2012CA2520475C Tumor-targeting drug-loaded particles
10/04/2012US20120252847 Novel form of s-omeprazole
10/04/2012US20120252726 Novel neurotrophic factors
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251559 Treatment of B-Cell Cancers With Anti-CD70 Antibody-Drug Conjugates
10/04/2012US20120251498 Gene Delivery to Organs
10/04/2012US20120251457 Methods and compositions for modulating adipocyte function
10/03/2012CN1846000B HPV CD8+ T-cell epitopes
10/03/2012CN1771053B Immunoglobulin formulation and method of preparation thereof
10/03/2012CN1729013B Broad spectrum anti-viral therapeutics and prophylaxis
10/03/2012CN102697790A Compounds and methods for delivery of prostacyclin analogs
10/03/2012CN102697737A Tumor-targeting drug-loaded particles
10/03/2012CN101284874B Peptide-based immunization therapy for treatment of atherosclerosis
10/02/2012CA2552266C Continuous method for producing bioactive molecule coated particles, bioactive molecule coated particles and uses therefor
10/02/2012CA2532594C Antiglucocorticoids for the treatment of catatonia
10/02/2012CA2532415C Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
10/02/2012CA2492883C Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/2012
09/27/2012US20120245334 Methods of using fet labeled oligonucleotides that include a 3'-5' exonuclease resistant quencher domain and compositions for practicing the same
09/27/2012US20120244182 Use of tryptanthrin compounds for immune potentiation
09/26/2012CN1791395B 免疫抑制剂化合物及组合物 Immunosuppressive compounds and compositions
09/25/2012US8273729 Treatment of irritable bowel syndrome and related bowel disease
09/25/2012US8273390 Methods and compositions for administration of TRPV1 agonists
09/25/2012US8273346 Method for increasing fructose digestion with strains of Bacillus coagulans and fructase
09/25/2012US8273331 Combination of medicament and lactose particles; accurate, uniform, consistent dispersion for multidose dry powder inhaler
09/25/2012CA2549522C Chewable soft capsules containing ungelatinized starch
09/25/2012CA2526556C Stable radiopharmaceutical compositions and methods for their preparation
09/25/2012CA2522994C Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
09/25/2012CA2478049C Humanized antibodies that recognize beta amyloid peptide
09/20/2012US20120238592 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocylcial Guanidine
09/19/2012EP2500438A2 Novel compositions and methods for the treatment of psoriasis
09/19/2012EP1666481B1 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 295